(877) 363-6376

HELPLINE

NEWS

MesoTV | Bringing Targeted Therapy to the Front Line with MTAP deleted Pleural Mesotheliomas

Our Director of Patient Services, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD, an oncologist and mesothelioma specialist at Memorial Sloan Kettering Cancer Center. They are discussing the current clinical trial “A Phase 1a/1b Basket Trial of BMS-986504 with Standard-of-Care Therapy For Patients with Metastatic MTAP-deleted Solid Tumors” offered at Memorial Sloan Kettering Cancer Center.

If you have any questions about clinical trials and if this trial could work for you or your loved one, please reach out to our Director of Patient Services, Julie White, at [email protected].

Our Sponsors

MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Belluck Law, Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); The Gori Law Firm; Merck; Early Luccarelli Sweeney & Meisenkothen, LLC; AstraZeneca

Search our previous episodes for topics/speakers of interest to you at www.curemeso.org/mesotv

Also...

In Other News

Peritoneal Panel

2026 International Symposium for Malignant Mesothelioma | October 23, 2026 | The Woodlands, Texas Joel Baumgartner, MD Hedy Kindler, MD Mecker Moller, MD Kanwal Raghav,

Read More »

Legal Panel

2026 International Symposium for Malignant Mesothelioma | October 23, 2026 | The Woodlands, Texas Moderated by: Cheryl Bruner This panel discussion brings together experienced attorneys

Read More »

Share:

Facebook
Twitter
LinkedIn